Fact based stock research
Shin Poong Pharm (KOSE:A019170)

KR7019170000

Shin Poong Pharm stock research in summary

shinpoong.co.kr


Shin Poong Pharm shares are more expensive than other comparable stocks. They are safely financed and show above average growth, but are poor value. We recommend evaluating whether the future of the company Shin Poong Pharm is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.


Latest Obermatt Ranks


Country South Korea
Industry Pharmaceuticals
Index
Size class Small

March 5, 2021. Stock data may be delayed. Login to get the most recent research.


Research History: Shin Poong Pharm

RESEARCH HISTORY 2018 2019 2020 2021
VALUE
VALUE
GROWTH
GROWTH
SAFETY
SAFETY
COMBINED
COMBINED

Last update of Combined Rank: 5-Mar-2021. Financial reporting date used for calculating ranks: 30-Sep-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better Shin Poong Pharm is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2018 2019 2020 2021
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)
DIVIDEND YIELD
DIVIDEND YIELD
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE

Last update of Value Rank: 5-Mar-2021. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Shin Poong Pharm; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2018 2019 2020 2021
REVENUE GROWTH
REVENUE GROWTH
PROFIT GROWTH
PROFIT GROWTH
STOCK RETURNS
STOCK RETURNS
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH

Last update of Growth Rank: 30-Sep-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Shin Poong Pharm.


Safety Metrics in Detail

SAFETY METRICS 2018 2019 2020 2021
LEVERAGE
LEVERAGE
REFINANCING
REFINANCING
LIQUIDITY
LIQUIDITY
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY

Last update of Safety Rank: 26-Feb-2021. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Shin Poong Pharm and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Shin Poong Pharm from March 5, 2021.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.

Get stock news now

Investing made easy